Migrating cancer stem cells — an integrated concept of malignant tumour progression
Top Cited Papers
- 1 September 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 5 (9) , 744-749
- https://doi.org/10.1038/nrc1694
Abstract
The dissemination of tumour cells is the prerequisite of metastases and is correlated with a loss of epithelial differentiation and the acquisition of a migratory phenotype, a hallmark of malignant tumour progression. A stepwise, irreversible accumulation of genetic alterations is considered to be the responsible driving force. But strikingly, metastases of most carcinomas recapitulate the organization of their primary tumours. Although current models explain distinct and important aspects of carcinogenesis, each alone can not explain the sum of the cellular changes apparent in human cancer progression. We suggest an extended, integrated model that is consistent with all aspects of human tumour progression - the 'migrating cancer stem (MCS)-cell' concept.Keywords
This publication has 49 references indexed in Scilit:
- Socializing with the NeighborsCell, 2004
- Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitorNature Medicine, 2003
- Epithelial–mesenchymal transitions in development and pathologiesCurrent Opinion in Cell Biology, 2003
- Applying the principles of stem-cell biology to cancerNature Reviews Cancer, 2003
- Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signalingNature Genetics, 2002
- The Wnt signalling pathwayJournal of Cell Science, 2002
- Tumor environment: a potent driving force in colorectal cancer?Trends in Molecular Medicine, 2001
- Putting tumours in contextNature Reviews Cancer, 2001
- Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environmentProceedings of the National Academy of Sciences, 2001
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997